超越完美的捐赠者:一个跨学科的方法来优化捐赠者利用率.
Aditi Venkatraman1, Lebei Pi2, David Belzile3
1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.
JACC. Advances
|May 1, 2025
概括
实施有针对性的干预措施使捐赠心脏的利用率翻了一番,达到18.5%,并将错过的可行性机会减少到8.6%. 这项研究改善了心脏移植效率,但没有对患者的治疗结果产生负面影响.
科学领域:
- 心脏病学 心脏病学
- 移植手术 移植手术
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 由于当前的接受实践,北美可行的捐赠心脏的大量浪费.
- 人们对移植心脏的需求越来越大.
- 需要改进的策略来最大限度地利用捐赠心脏.
研究的目的:
- 将捐赠人心脏利用率提高到20%的目标.
- 将错过的可活性捐赠心脏机会减少到≤10%.
- 评估干预措施对初级移植功能障碍的影响.
主要方法:
- 预期单中心研究 (2021-2023) 分析捐赠心脏供应.
- 根据特定的捐赠者标准 (例如,LVEF,年龄,缺血时间) 定义了错过的可行的机会.
- 实施的干预措施:实时利用仪表板,国际演讲系列和捐助者报告卡.
主要成果:
- 供体心脏利用率从12.4% (干预前) 增加到18.5% (干预后) (P=0.038).
- 错过的可行的机会显著下降,从19.3%降至8.6% (P<0.001).
- 干预后观察到一种减少严重初级移植功能障碍的趋势 (26%对12%,P=0.121).
结论:
- 跨学科,多方面的干预措施有效地使捐赠心脏利用率翻了一番.
- 实现了错失可行的机会的显著减少.
- 短期心脏移植接受者的结果没有受到干预的影响.
相关概念视频
Tissue Transplantation
271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260


